Lokal Anestezik İlaç Zehirlenmeleri

Authors

Ertan Ararat

Synopsis

Lokal anestezik ilaçlar; minör ve lokal cerrahi işlemleri kolaylaştırmak, rejyonel anestezi sağlamak ve kardiyak disritmi tedavisi amacıyla yaygın olarak kullanılmaktadır. Aromatik halka, intermediate ester veya amid zinciri ile terminal amin gruplarından oluşan bu moleküller, voltaj kapılı sodyum kanallarını bloke ederek impuls iletimini reversible şekilde inhibe eder. Metabolizma yollarına göre ester ve amid yapıda sınıflandırılan lokal anesteziklerin klinik kullanımı sırasında; yüksek doz uygulamaları, istemsiz intravasküler enjeksiyonlar, ileri yaş, organ yetmezlikleri ve asidoz gibi faktörlere bağlı olarak lokal anestezik ilişkili sistemik toksisite (LAST) gelişebilmektedir. Toksisiteyi önlemede doz azaltımı, ultrason ve periferik sinir stimülasyonu rehberliği ile bölünmüş doz uygulamaları önceliklidir. Klinik belirtiler santral sinir sistemi eksitasyonu ve depresyonu bulgularından, hipertansiyon, bradikardi, kardiyak ileti bozuklukları, kardiyak kollaps ve asistoliye kadar ilerleyebilir. Tedavide ilaç uygulamasının derhal durdurulması, havayolunun güvenceye alınması, konvülsiyonların benzodiazepinlerle kontrolü ve %20’lik Intralipid emülsiyon tedavisi temel basamakları oluşturur; dirençli olgularda ECMO tedavisi düşünülmelidir. Ek olarak Lidokain gibi ajanlar, hemoglobindeki demiri ferrik forma oksitleyerek doku hipoksisine yol açan methemoglobinemiye neden olabilir. Methemoglobinemi yönetiminde ilacın kesilmesi ve oksijen desteğinin yanı sıra Metilen Mavisi uygulanır; G6PD eksikliğinde ise Askorbik Asit tercih edilmelidir.

Local anesthetic drugs are widely used to facilitate minor and local surgical procedures, provide regional anesthesia, and treat cardiac dysrhythmias. Composed of an aromatic ring, an intermediate ester or amide chain, and terminal amine groups, these molecules reversibly inhibit impulse conduction by blocking voltage-gated sodium channels. Classified as esters or amides based on their metabolic pathways, the clinical use of local anesthetics can lead to local anesthetic systemic toxicity (LAST) due to factors such as high-dose applications, inadvertent intravascular injections, advanced age, organ failure, and acidosis. To prevent toxicity, dose reduction, ultrasound and peripheral nerve stimulation guidance, and fractionated dosing applications are prioritized. Clinical manifestations can progress from central nervous system excitation and depression signs to hypertension, bradycardia, cardiac conduction disorders, cardiac collapse, and asystole. The primary steps of treatment include immediately stopping the drug administration, securing the airway, controlling convulsions with benzodiazepines, and administering 20% Intralipid emulsion therapy; ECMO therapy should be considered in refractory cases. Additionally, agents such as Lidocaine can cause methemoglobinemia by oxidizing iron in hemoglobin to the ferric form, leading to tissue hypoxia. In the management of methemoglobinemia, along with drug discontinuation and oxygen support, Methylene Blue is administered, whereas Ascorbic Acid should be preferred in cases of G6PD deficiency.

References

Rubin DS, Matsumoto M, Weinberg G, Roth S. Local anesthetic systemic toxicity in total joint arthroplasty: incidence and risk factors in the United States from the National Inpatient Sample 1998– 2013. Reg Anesth Pain Med. 2018;43(2):131–7

Dickerson DM, Apfelbaum JL. Local anesthetic systemic toxicity. Aesthet Surg J. 2014 Sep;34(7):1111-9. doi: 10.1177/1090820X14543102. Epub 2014 Jul 15. PMID: 25028740.

Waldinger R, Weinberg G, Gitman M. Local Anesthetic Toxicity in the Geriatric Population. Drugs Aging. 2020 Jan;37(1):1-9. doi: 10.1007/s40266-019-00718-0. PMID: 31598909.

Neal JM, Bernards CM, Butterworth JF 4th, Di Gregorio G, Drasner K, Hejtmanek MR, Mulroy MF, Rosenquist RW, Weinberg GL. ASRA practice advisory on local anesthetic systemic toxicity. Reg Anesth Pain Med. 2010;35:152–61.

Mulroy MF, Hejtmanek MR. Prevention of local anesthetic systemic toxicity. Reg Anesth Pain Med. 2010;35:177–80.

Rosenberg PH, Veering BT, Urmey WF. Maximum recommended doses of local anesthetics: a multifactorial concept. Reg Anesth Pain Med. 2004;29:564–75.

Wolfe JW, Butterworth JF. Local anesthetic systemic toxicity: update on mechanisms and treatment. Curr Opin Anaesthesiol. 2011;24:561–6.

Guay J. The epidural test dose: a review. Anesth Analg. 2006;102:921–9.

Neal JM, Brull R, Horn JL, Liu SS, McCartney CJ, Perlas A, Salinas FV, Tsui BC. The Second American Society of Regional Anesthesia and Pain Medicine Evidence-Based Medicine Assessment of Ultrasound-Guided Regional Anesthesia: Executive Summary. Reg Anesth Pain Med.2016Mar-Apr;41(2):181-94. doi: 10.1097/AAP.0000000000000331. PMID: 26695878.

Lewis SR, Price A, Walker KJ, McGrattan K, Smith AF. Ultrasound guidance for upper and lower limb blocks. Cochrane Database Syst Rev. 2015Sep11;2015(9):CD006459. doi: 10.1002/14651858.CD006459.pub3. PMID: 26361135; PMCID: PMC6465072.

Neal JM, Mulroy MF, Weinberg GL. American Society of Regional Anesthesia and Pain Medicine. Checklist for managing local anesthetic systemic toxicity: treatment of local anesthetic systemic toxicity: 2012 version. Reg Anesth Pain Med.2012;37:16–8.

Safety Committee of Japanese Society of Anesthesiologists. Practical guide for the management of systemic toxicity caused by local anesthetics. J Anesth. 2019 Feb;33(1):1-8. doi: 10.1007/s00540-018-2542-4. Epub 2018 Nov 11. PMID: 30417244.

Cave G, Harrop-Griffiths W, Harvey M, Meek T, Picard J, Short T, Weinberg G. AAGBI safety guideline: management of severe local anaesthetic toxicity. 5 Aralık 2020 tarihinde https ://www.aagbi .org/sites /defau lt/files /la_toxic ity_2010_0.pdf. adresinden ulaşılmıştır.

Gitman M, Barrington MJ. Local anesthetic systemic toxicity:a review of recent case reports and registries. Reg Anesth PainMed. 2018;43(2):124–30. https ://doi.org/10.1097/AAP.00000 00000 00072 1.

Cole, J.B. (2018). Environment and Toxicology Part 4,Section 2. Ron M. WALLS(Ed.), 9th Edition Rosen’s Emergency Medicine Concepts and Clinical Practice(s.1884). Philadelphia,Elsevier.

Neal JM, Barrington MJ, Fettiplace MR, Gitman M, Memtsoudis SG, Mörwald EE, Rubin DS, Weinberg G. The Third American Society of Regional Anesthesia and Pain Medicine Practice Advisory on Local Anesthetic Systemic Toxicity: Executive Summary 2017. Reg Anesth Pain Med. 2018 Feb;43(2):113-123. doi: 10.1097/AAP.0000000000000720. PMID: 29356773.

Hayes BD, Gosselin S, Calello DP, Nacca N, Rollins CJ, Abourbih D, et al. Systematic review of clinical adverse events reported after acute intravenous lipid emulsion administration. Clin Toxicol. 2016;54(5):365–404.

Froehle M, Haas NA, Kirchner G, Kececioglu D, Sandica E. ECMO for Cardiac Rescue after Accidental Intravenous Mepivacaine Application. Case Rep Pediatr. 2012;2012:491692. doi: 10.1155/2012/491692. Epub 2012 Aug 27. PMID: 22966472; PMCID: PMC3433119.

Bacon B, Silverton N, Katz M, Heath E, Bull DA, Harig J, Tonna JE. Local Anesthetic Systemic Toxicity Induced Cardiac Arrest After Topicalization for Transesophageal Echocardiography and Subsequent Treatment With Extracorporeal Cardiopulmonary Resuscitation. J Cardiothorac Vasc Anesth. 2019 Jan;33(1):162-165. doi: 10.1053/j.jvca.2018.01.044. Epub 2018 Jan 31. PMID: 29525187; PMCID: PMC6068002.

Barash M, Reich KA, Rademaker D. Lidocaine-induced methemoglobinemia: a clinical reminder. J Am Osteopath Assoc. 2015 Feb;115(2):94-8. doi: 10.7556/jaoa.2015.020. PMID: 25637615.

Ludlow JT, Wilkerson RG, Nappe TM. Methemoglobinemia. 2020 Sep 4. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan–. PMID: 30726002.

Downloads

Published

April 6, 2021

License

License